Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 18, 2026
Sale
Shares
14,200
Price
$62.12
Total Value
$882.10K
Shares Held After
1,224,723
% of Holdings
1.1%

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Reynoso Jamie L. — CEO, Medicare Advantage
Mar 18, 2026
Sale
Shares
5,833
Price
$1.91
Total Value
$11.14K
Shares Held After
2,716,735
% of Holdings
0.2%
Mar 18, 2026
Sale
Shares
19,060
Price
$13.18
Total Value
$251.21K
Shares Held After
494,920
% of Holdings
3.7%
Mar 18, 2026
Purchase
Shares
15,000
Price
$14.89
Total Value
$223.35K
Shares Held After
15,001
% of Holdings
100.0%
Mar 18, 2026
Sale
Shares
412
Price
$50.48
Total Value
$20.80K
Shares Held After
17,044
% of Holdings
2.4%
Mar 18, 2026
Sale
Shares
6,838
Price
$49.55
Total Value
$338.82K
Shares Held After
17,456
% of Holdings
28.1%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Mar 18, 2026
Sale
Shares
1,930
Price
$62.07
Total Value
$119.80K
Shares Held After
78,185
% of Holdings
2.4%
Mar 17, 2026
Sale
Shares
5,280
Price
$51.66
Total Value
$272.76K
Shares Held After
90,920
% of Holdings
5.5%

CytomX Therapeutics, Inc. (CTMX)

Chu Yu-Waye — Chief Medical Officer
Mar 17, 2026
Sale
Shares
21,279
Price
$6.42
Total Value
$136.68K
Shares Held After
189,446
% of Holdings
10.1%

Revolution Medicines, Inc. (RVMD)

Wang Xiaolin — EVP, Clinical Development
Mar 17, 2026
Sale
Shares
2,010
Price
$99.48
Total Value
$199.96K
Shares Held After
116,063
% of Holdings
1.7%

Revolution Medicines, Inc. (RVMD)

Cislini Jeff — General Counsel
Mar 17, 2026
Sale
Shares
1,795
Price
$99.48
Total Value
$178.57K
Shares Held After
59,681
% of Holdings
2.9%

Revolution Medicines, Inc. (RVMD)

Anders Jack — Chief Financial Officer
Mar 17, 2026
Sale
Shares
2,753
Price
$99.48
Total Value
$273.87K
Shares Held After
125,512
% of Holdings
2.1%
Mar 17, 2026
Sale
Shares
10,972
Price
$69.42
Total Value
$761.68K
Shares Held After
57,052
% of Holdings
16.1%

Revolution Medicines, Inc. (RVMD)

Wei Lin — Chief Medical Officer
Mar 17, 2026
Sale
Shares
2,073
Price
$99.48
Total Value
$206.22K
Shares Held After
101,366
% of Holdings
2.0%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — President, Research and Development
Mar 17, 2026
Sale
Shares
4,302
Price
$99.48
Total Value
$427.96K
Shares Held After
295,398
% of Holdings
1.4%
Mar 17, 2026
Purchase
Shares
303,300
Price
$11.20
Total Value
$3.40M
Shares Held After
6,349,624
% of Holdings
4.8%
Mar 17, 2026
Sale
Shares
12,871
Price
$99.48
Total Value
$1.28M
Shares Held After
276,698
% of Holdings
4.4%

Revolution Medicines, Inc. (RVMD)

Horn Margaret A — Chief Operating Officer
Mar 17, 2026
Sale
Shares
4,583
Price
$99.48
Total Value
$455.92K
Shares Held After
157,570
% of Holdings
2.8%

Tarsus Pharmaceuticals, Inc. (TARS)

Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Mar 17, 2026
Sale
Shares
2,111
Price
$69.42
Total Value
$146.55K
Shares Held After
47,635
% of Holdings
4.2%

Tarsus Pharmaceuticals, Inc. (TARS)

Neervannan Seshadri — Chief Operating Officer
Mar 17, 2026
Sale
Shares
3,125
Price
$69.42
Total Value
$216.94K
Shares Held After
93,979
% of Holdings
3.2%

Tarsus Pharmaceuticals, Inc. (TARS)

Lin Elizabeth Yeu — Chief Medical Officer
Mar 17, 2026
Sale
Shares
375
Price
$69.42
Total Value
$26.03K
Shares Held After
24,077
% of Holdings
1.5%

Tarsus Pharmaceuticals, Inc. (TARS)

Mottiwala Aziz — Chief Commercial Officer
Mar 17, 2026
Sale
Shares
4,286
Price
$69.42
Total Value
$297.53K
Shares Held After
70,250
% of Holdings
5.8%

Tarsus Pharmaceuticals, Inc. (TARS)

Whitfield Dianne C. — Chief Human Resources Officer
Mar 17, 2026
Sale
Shares
4,029
Price
$69.42
Total Value
$279.69K
Shares Held After
43,273
% of Holdings
8.5%

Tarsus Pharmaceuticals, Inc. (TARS)

Wahl Bryan — General Counsel
Mar 17, 2026
Sale
Shares
4,084
Price
$69.42
Total Value
$283.51K
Shares Held After
72,315
% of Holdings
5.3%

CytomX Therapeutics, Inc. (CTMX)

Ogden Christopher — Chief Financial Officer
Mar 17, 2026
Sale
Shares
19,323
Price
$6.42
Total Value
$124.11K
Shares Held After
296,948
% of Holdings
6.1%
Mar 17, 2026
Sale
Shares
118,969
Price
$6.42
Total Value
$764.14K
Shares Held After
1,078,922
% of Holdings
9.9%

CytomX Therapeutics, Inc. (CTMX)

BELVIN MARCIA — SVP, Chief Scientific Officer
Mar 17, 2026
Sale
Shares
31,492
Price
$6.42
Total Value
$202.27K
Shares Held After
300,760
% of Holdings
9.5%

Roivant Sciences Ltd. (ROIV)

Venker Eric — President & Immunovant CEO
Mar 17, 2026
Sale
Shares
200,000
Price
$28.24
Total Value
$5.65M
Shares Held After
1,647,546
% of Holdings
10.8%

Enliven Therapeutics, Inc. (ELVN)

Collins Helen Louise — CHIEF MEDICAL OFFICER
Mar 17, 2026
Sale
Shares
5,000
Price
$27.76
Total Value
$138.80K
Shares Held After
25,000
% of Holdings
16.7%
Mar 17, 2026
Sale
Shares
500
Price
$21.81
Total Value
$10.90K
Shares Held After
20,136
% of Holdings
2.4%

Stoke Therapeutics, Inc. (STOK)

Allan Jonathan — GENERAL COUNSEL & CORP SEC
Mar 17, 2026
Sale
Shares
1,791
Price
$33.38
Total Value
$59.78K
Shares Held After
33,464
% of Holdings
5.1%

Pacira BioSciences, Inc. (PCRX)

SLONIN JONATHAN — Chief Medical Officer
Mar 17, 2026
Sale
Shares
3,261
Price
$22.82
Total Value
$74.42K
Shares Held After
223,640
% of Holdings
1.4%

Stoke Therapeutics, Inc. (STOK)

Allan Jonathan — GENERAL COUNSEL & CORP SEC
Mar 17, 2026
Sale
Shares
2,476
Price
$32.74
Total Value
$81.06K
Shares Held After
35,255
% of Holdings
6.6%

Stoke Therapeutics, Inc. (STOK)

Hoitt Jason — Chief Patient Officer
Mar 17, 2026
Sale
Shares
748
Price
$33.38
Total Value
$24.96K
Shares Held After
12,207
% of Holdings
5.8%

Stoke Therapeutics, Inc. (STOK)

Hoitt Jason — Chief Patient Officer
Mar 17, 2026
Sale
Shares
1,033
Price
$32.74
Total Value
$33.82K
Shares Held After
12,955
% of Holdings
7.4%

Stoke Therapeutics, Inc. (STOK)

Leggett Thomas — Chief Financial Officer
Mar 17, 2026
Sale
Shares
922
Price
$33.38
Total Value
$30.77K
Shares Held After
12,554
% of Holdings
6.8%

Stoke Therapeutics, Inc. (STOK)

Leggett Thomas — Chief Financial Officer
Mar 17, 2026
Sale
Shares
1,274
Price
$32.74
Total Value
$41.71K
Shares Held After
13,476
% of Holdings
8.6%

Stoke Therapeutics, Inc. (STOK)

Ticho Barry — CHIEF MEDICAL OFFICER
Mar 17, 2026
Sale
Shares
2,587
Price
$33.38
Total Value
$86.34K
Shares Held After
47,484
% of Holdings
5.2%

Stoke Therapeutics, Inc. (STOK)

Ticho Barry — CHIEF MEDICAL OFFICER
Mar 17, 2026
Sale
Shares
3,577
Price
$32.74
Total Value
$117.11K
Shares Held After
50,071
% of Holdings
6.7%
Mar 17, 2026
Sale
Shares
31,707
Price
$455.30
Total Value
$14.44M
Shares Held After
15,000
% of Holdings
67.9%
Mar 17, 2026
Purchase
Shares
24,218
Price
$33.56
Total Value
$812.84K
Shares Held After
1,146,631
% of Holdings
2.1%
Mar 17, 2026
Purchase
Shares
75,782
Price
$33.00
Total Value
$2.50M
Shares Held After
1,122,413
% of Holdings
6.8%
Mar 17, 2026
Sale
Shares
15,000
Price
$20.27
Total Value
$304.12K
Shares Held After
364,786
% of Holdings
3.9%

GLAUKOS Corp (GKOS)

Thurman Alex R. — SVP & CHIEF FINANCIAL OFFICER
Mar 17, 2026
Sale
Shares
625
Price
$99.15
Total Value
$61.97K
Shares Held After
49,249
% of Holdings
1.3%

INCYTE CORP (INCY)

CAGNONI PABLO J — President, R&D
Mar 17, 2026
Sale
Shares
18,667
Price
$94.24
Total Value
$1.76M
Shares Held After
234,800
% of Holdings
7.4%
Mar 17, 2026
Sale
Shares
18,650
Price
$25.93
Total Value
$483.59K
Shares Held After
22,129
% of Holdings
45.7%
Mar 17, 2026
Sale
Shares
4,269
Price
$11.92
Total Value
$50.89K
Shares Held After
160,449
% of Holdings
2.6%

PROCEPT BioRobotics Corp (PRCT)

Nouri Alaleh — EVP, CLO, CORP. SEC.
Mar 17, 2026
Sale
Shares
304
Price
$28.15
Total Value
$8.56K
Shares Held After
110,717
% of Holdings
0.3%
Mar 17, 2026
Sale
Shares
706
Price
$28.15
Total Value
$19.88K
Shares Held After
151,558
% of Holdings
0.5%
Mar 17, 2026
Sale
Shares
62,102
Price
$30.14
Total Value
$1.87M
Shares Held After
224,940
% of Holdings
21.6%
Version: v26.3.29